Senior Economist, Co-Director of Drug Policy Research Center, RAND Corporation
Rosalie Liccardo Pacula is a senior economist at the RAND Corporation and a professor at the Pardee RAND Graduate School. She serves as director of RAND’s BING Center for Health Economics, co-director of RAND’s Drug Policy Research Center, and co-principal investigator of RAND’s Opioid Policy Tools and Information Center of Excellence. Her research focuses on issues related to illegal or imperfect markets (health care markets, insurance markets, markets for addictive goods); the measurement of these markets; the impact they have on behavior; and the effectiveness of policy interventions at targeting behavior in them.
Dr. Pacula has applied much of this knowledge to study addiction, addiction policy, and the healthcare system delivery of treatment for addiction services. She was lead investigator of several National Institutes of Health (NIH) studies examining the impact of cannabis liberalization policies (decriminalization, medicalization, and legalization) on use and public health, as well as their impact on the use of other substances (alcohol, prescription opioids, and heroin) and is currently leading NIH-funded research constructing a state-level cannabis policy index and examining the impact of cannabis availability in local markets on medical and non-medical use of cannabis and opioids. She received her PhD in economics from Duke University.